Enzyme-responsive nanoparticles for drug release and diagnostics.
about
Upconversion Nanoparticles for Bioimaging and Regenerative MedicineThe Smart Drug Delivery System and Its Clinical PotentialVersatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined RoutingInorganic nanosystems for therapeutic delivery: status and prospectsEnzyme-responsive nanomaterials for controlled drug deliveryNanobiocatalyst advancements and bioprocessing applicationsChemophototherapy: An Emerging Treatment Option for Solid TumorsProtease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.Novel delivery approaches for cancer therapeutics.Stimuli-responsive nanomaterials for biomedical applicationsCO2 bubbling-based 'Nanobomb' System for Targetedly Suppressing Panc-1 Pancreatic Tumor via Low Intensity Ultrasound-activated Inertial Cavitation.Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy.Multifunctional polymeric micelles for delivery of drugs and siRNA.Ultrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes.25th anniversary article: interfacing nanoparticles and biology: new strategies for biomedicine.Bioinspired Mechano-Sensitive Macroporous Ceramic Sponge for Logical Drug and Cell Delivery.Mmp-9 responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancer.Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.Strategies for advancing cancer nanomedicine.Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis.Phospholipase A2-responsive antibiotic delivery via nanoparticle-stabilized liposomes for the treatment of bacterial infectionNanomedical engineering: shaping future nanomedicines.Stimuli-responsive nanomaterials for therapeutic protein delivery.Porphyrin-phospholipid liposomes with tunable leakiness.Near-Infrared-Triggered Azobenzene-Liposome/Upconversion Nanoparticle Hybrid Vesicles for Remotely Controlled Drug Delivery to Overcome Cancer Multidrug Resistance.Nanotechnology-based approaches in anticancer researchDoxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release.Stimuli-responsive nanoparticles for targeting the tumor microenvironment.What is the role of curvature on the properties of nanomaterials for biomedical applications?Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlookGold Nanoparticles for In Vitro Diagnostics.Design, challenge, and promise of stimuli-responsive nanoantibiotics.Smart Mesoporous Nanomaterials for Antitumor Therapy.Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse ModelsStrategies for using nanoprobes to perceive and treat cancer activity: a review.Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.Quantum dot-based nanosensors for diagnosis via enzyme activity measurement.Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions.
P2860
Q26744465-67555C6B-6AFB-4570-886B-2CE68BCDA594Q26744837-B6277549-3D61-4699-AD91-CB5E0CA3A158Q26746171-B6FAE00B-DBD4-43BE-A5C6-6FFA01285EDDQ26827968-F9255A38-DD19-4F6C-A7D1-73E056F68723Q26992127-CDA73922-A8D9-4677-ACE5-C5B517F488EEQ27003905-5D8A4015-59C8-407E-B408-A398BD85E959Q28468315-F75D67B3-808F-4BFC-9BE8-2765A810EA00Q30355600-153030DE-D347-42F1-9CFC-DDA271F9A333Q30361646-72A11804-F533-4D6C-9713-AB24C48358EFQ30362001-9306148B-92B5-4436-8C6A-BDD208B4BCFDQ30368171-EDB7DF20-292C-41BD-942B-83F4991D5DCAQ30396768-45B61669-D98F-4E31-9CE3-69E36F97387EQ30402935-15D49C90-A1C6-4529-8DF3-D7FF1D6A85FBQ30421668-89D4EDD5-3A56-4FFB-83AE-C01E4344DF08Q30438973-FE21C166-A465-40B4-B157-2373FABA9293Q30449753-F8B40FCF-489D-4824-BFA6-3033658168FEQ33793138-D72ED92D-8034-416E-89BC-B6C63BE693DEQ33806288-B655FC1D-4E2D-4BB5-A03C-B3F6CF9D5E3EQ33894617-42C445CB-58C3-4129-8C95-4D630CE5C1D8Q33902253-0F48E148-BA8B-4938-BBBB-2FFFAF5B519CQ33995719-189D4269-0949-4909-B9C0-BFA9DD38A158Q34369626-5C18A84F-869B-4726-A727-85A8C0F283FDQ34770794-47BB7E7E-CF94-4A49-859D-0DBA40F36441Q35019550-0DDFB571-0ACA-49C5-9AE3-DA8C424C6615Q35088244-B7E40D4D-1B71-4BAE-843F-1BB0BDD1B819Q35844575-8597746B-3F65-4468-96FF-0E539D8B6500Q36118030-0A2E4132-9C01-4DB8-8280-26AEFC1D6500Q36168983-373B1F04-9E12-4D2F-9DC8-84FE164223D4Q36278952-3B412415-CFF2-4C8B-9EDF-6510BA16B1E8Q36307519-205B9C11-466E-4814-9450-E3F5D1168549Q36626083-CA396618-B768-4272-9087-FD6D511D149EQ37538055-AFC90B4F-50B4-45E4-80E2-ED5D9BC24243Q37580069-286AAB99-D035-47A3-AC13-A649B872D88DQ37610372-40D8D4AD-ABD4-4F3E-8191-90DE24B7EAC9Q37638621-2C95D745-509A-4BE6-A15C-B4B3F234F88AQ37668583-E81827CC-90D9-4415-A45D-A2194FEC7A02Q37719564-46356B53-66F0-4433-9EAE-4E79CD0CD117Q38095361-A155C36C-D848-43B1-9063-E4AA7AC4B49AQ38103594-86463E6D-C0A2-4790-8DC5-BA39F8A8A2A0Q38136246-6B98C16B-A26E-469E-820B-D86FFBF519E8
P2860
Enzyme-responsive nanoparticles for drug release and diagnostics.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Enzyme-responsive nanoparticles for drug release and diagnostics.
@en
Enzyme-responsive nanoparticles for drug release and diagnostics.
@nl
type
label
Enzyme-responsive nanoparticles for drug release and diagnostics.
@en
Enzyme-responsive nanoparticles for drug release and diagnostics.
@nl
prefLabel
Enzyme-responsive nanoparticles for drug release and diagnostics.
@en
Enzyme-responsive nanoparticles for drug release and diagnostics.
@nl
P1476
Enzyme-responsive nanoparticles for drug release and diagnostics
@en
P2093
Molly M Stevens
Roberto de la Rica
P304
P356
10.1016/J.ADDR.2012.01.002
P407
P50
P577
2012-01-14T00:00:00Z